Ezekowitz Alan 4
Research Summary
AI-generated summary
Organon (OGN) Director Alan Ezekowitz Receives Award
What Happened Alan Ezekowitz, a director of Organon & Co. (OGN), received a grant of 17,857.143 phantom stock units on June 12, 2026. The units were recorded at $13.44 each for a total economic value of $240,000. This was an award (derivative phantom units), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-12; Filing date: 2026-06-15 (timely filing).
- Instrument: 17,857.143 phantom stock units, $13.44 per unit, total $240,000 (transaction code A — award/grant; derivative).
- Holdings after transaction: Not specified in the filing. The report notes prior phantom units acquired via dividend reinvestment on 9/11/2025, 12/11/2025, 3/12/2026 and 6/11/2026.
- Plan and settlement: Units granted under the Organon Non-Employee Director Savings Plan and are 1-for-1 economic equivalents to common shares; payable in cash upon settlement after the director’s termination of service.
- No sale, exercise, or tax-withholding event reported in this filing.
Context Phantom stock units are cash-settled awards that track the value of common shares and are commonly used for non-employee director compensation. Because these units pay out in cash after a director leaves service, they are compensation rather than an immediate purchase of stock and do not by themselves signal a personal buy or sell decision.